GLP1R and metabolic dysfunction-associated steatotic liver disease: Indeed, among other effects, GLP-1R agonists promote weight loss, induce satiety, and reduce insulin resistance, effects that can all improve NAFLD independently of direct activation of hepatic GLP-1Rs [30].